Gavin P. Dunn - Concepedia

Author

Gavin P. Dunn

Washington University in St. Louis ORCID

Also Known As

A. Humphreys, Alexandros Bouras, Cho, Juok, Dunn, Gavin, Dunn, Gavin P., G Dunn, G. Dunn, G. P. Dunn, G.P. Dunn, Gavin Dunn

1.1K

Publications

30K

Citations

H-Index

Concepts

All Affiliations

Washington University in St. Louis Neurological Surgery Massachusetts General Hospital Harvard University Dana-Farber Cancer Institute

About

Gavin P. Dunn is an author at Washington University in St. Louis specializing in medicine, tumor microenvironment, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	27	3.2K
2	Health Sciences	7	7	762
3	Engineering	3	3	179
4	Biology	1	1	125
5	Biostatistics	1	1	25

Gavin P. Dunn

Publications

8.8K

Citations

H-Index

Page 1

	Year	Citations
Type I interferon is selectively required by dendritic cells for immune rejection of tumors Mark S. Diamond, Michelle Kinder, Hirokazu Matsushita, The Journal of Experimental Medicine	2011	1K
Comprehensive Analysis of Hypermutation in Human Cancer Brittany Campbell, Nicholas Light, David Fabrizio, Cell Somatic VariantCancer GenomicsComprehensive AnalysisMedicineCell Biology	2017	772
T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma Karolina Woroniecka, Pakawat Chongsathidkiet, Kristen E. Rhodin, Clinical Cancer Research	2018	610
A critical function for type I interferons in cancer immunoediting Gavin P. Dunn, Allen T. Bruce, Kathleen C. F. Sheehan, Nature Immunology Cancer ImmunosurveillanceImmunologyTumor ImmunityPathologyImmunologic Mechanism	2005	593
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial Ravindra Uppaluri, Katie M. Campbell, Ann Marie Egloff, Clinical Cancer Research	2020	342
Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline <i>POLE</i> Deficiency Treated with Checkpoint Blockade Immunotherapy Tanner M. Johanns, Christopher A. Miller, Ian G. Dorward, Cancer Discovery	2016	291
Blocking Monoclonal Antibodies Specific for Mouse IFN- <i>α</i> / <i>β</i> Receptor Subunit 1 (IFNAR-1) from Mice Immunized by <i>In Vivo</i> Hydrodynamic Transfection Kathleen C. F. Sheehan, Koon Siew Lai, Gavin P. Dunn, Journal of Interferon & Cytokine Research	2006	259
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases Timothy J. Kaufmann, Marion Smits, Jerrold L. Boxerman, Neuro-Oncology Oncologic ImagingHigh-grade GliomasGliomaMagnetic Resonance ImagingNeuro-oncology	2020	241
Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM W. Ruprecht Wiedemeyer, Ian F. Dunn, Steven N. Quayle, Proceedings of the National Academy of Sciences Cell ProliferationHigh-grade GliomasCancer BiologyGliomaTumor Biology	2010	224
ERK1/2 Regulation of CD44 Modulates Oral Cancer Aggressiveness Nancy P. Judd, Ashley E. Winkler, Oihana Murillo, Cancer Research Erk1/2 RegulationOncologyCd44 ExpressionMedicineImmunology	2011	224

Page 1